These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 16085405)

  • 1. KIR matching in hematopoietic stem cell transplantation.
    Bignon JD; Gagne K
    Curr Opin Immunol; 2005 Oct; 17(5):553-9. PubMed ID: 16085405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of donor natural killer cell alloreactivity on allogeneic hematopoietic transplantation.
    Ruggeri L; Capanni M; Mancusi A; Martelli MF; Velardi A
    Transpl Immunol; 2005 Aug; 14(3-4):203-6. PubMed ID: 15982564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The beneficial role of inhibitory KIR genes of HLA class I NK epitopes in haploidentically mismatched stem cell allografts may be masked by residual donor-alloreactive T cells causing GVHD.
    Bishara A; De Santis D; Witt CC; Brautbar C; Christiansen FT; Or R; Nagler A; Slavin S
    Tissue Antigens; 2004 Mar; 63(3):204-11. PubMed ID: 14989709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of killer immunoglobulin-like receptor/HLA ligand matching on achievement of T-cell complete donor chimerism in related donor nonmyeloablative allogeneic hematopoietic stem cell transplantation.
    Sobecks RM; Ball EJ; Askar M; Theil KS; Rybicki LA; Thomas D; Brown S; Kalaycio M; Andresen S; Pohlman B; Dean R; Sweetenham J; Macklis R; Bernhard L; Cherni K; Copelan E; Maciejewski JP; Bolwell BJ
    Bone Marrow Transplant; 2008 Apr; 41(8):709-14. PubMed ID: 18195688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expansion of NKG2A-LIR1- natural killer cells in HLA-matched, killer cell immunoglobulin-like receptors/HLA-ligand mismatched patients following hematopoietic cell transplantation.
    Rathmann S; Glatzel S; Schönberg K; Uhrberg M; Follo M; Schulz-Huotari C; Kaymer M; Veelken H; Finke J; Fisch P
    Biol Blood Marrow Transplant; 2010 Apr; 16(4):469-81. PubMed ID: 20044012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relevance of KIR gene matching in unrelated hematopoietic stem cell transplantations.
    Gagne K; Busson M; Balere-Appert ML; Absi L; Jollet I; Bignon JD; Bois M; Dormoy A; Dubois V; Gebuhrer L; Loiseau P; Masson D; Moine A; Perrier P; Reviron D; Charron D; Raffoux C;
    Tissue Antigens; 2007 Apr; 69 Suppl 1():118-22. PubMed ID: 17445183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Donor KIR3DL1/3DS1 gene and recipient Bw4 KIR ligand as prognostic markers for outcome in unrelated hematopoietic stem cell transplantation.
    Gagne K; Busson M; Bignon JD; Balère-Appert ML; Loiseau P; Dormoy A; Dubois V; Perrier P; Jollet I; Bois M; Masson D; Moine A; Absi L; Blaise D; Charron D; Raffoux C;
    Biol Blood Marrow Transplant; 2009 Nov; 15(11):1366-75. PubMed ID: 19822295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural killer-cell activity after human renal transplantation in relation to killer immunoglobulin-like receptors and human leukocyte antigen mismatch.
    Vampa ML; Norman PJ; Burnapp L; Vaughan RW; Sacks SH; Wong W
    Transplantation; 2003 Oct; 76(8):1220-8. PubMed ID: 14578757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of KIRs and KIR ligands in hematopoietic transplantation.
    Velardi A
    Curr Opin Immunol; 2008 Oct; 20(5):581-7. PubMed ID: 18675345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of killer cell immunoglobulin-like receptor genotypes on acute graft-vs-host disease after unrelated hematopoietic stem cell transplantation in Koreans.
    Kim SY; Choi HB; Yoon HY; Choi EJ; Cho B; Kim HK; Kim YJ; Kim HJ; Min CK; Kim DW; Lee JW; Min WS; Kim CC; Kim TG
    Tissue Antigens; 2007 Apr; 69 Suppl 1():114-7. PubMed ID: 17445182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patients benefit from the addition of KIR repertoire data to the donor selection procedure for unrelated haematopoietic stem cell transplantation.
    Schellekens J; Rozemuller EH; Petersen EJ; van den Tweel JG; Verdonck LF; Tilanus MG
    Mol Immunol; 2008 Feb; 45(4):981-9. PubMed ID: 17881057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Study on the behavior of NK cell KIRs of donor/recipient pairs in HLA matched unrelated allo-HSCT].
    Bao XJ; He J; Chen ZX; Wu DP; Yao L; Yuan XN; Cen JN; Qiu QC; Di WY; Zhang H; Zhang J; Zhou XH; Xu HX
    Zhonghua Xue Ye Xue Za Zhi; 2007 Aug; 28(8):510-3. PubMed ID: 18078124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognosis after unmanipulated HLA-haploidentical blood and marrow transplantation is correlated to the numbers of KIR ligands in recipients.
    Zhao XY; Huang XJ; Liu KY; Xu LP; Liu DH
    Eur J Haematol; 2007 Apr; 78(4):338-46. PubMed ID: 17378893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KIR/HLA ligand incompatibility in kidney transplantation.
    Kunert K; Seiler M; Mashreghi MF; Klippert K; Schönemann C; Neumann K; Pratschke J; Reinke P; Volk HD; Kotsch K
    Transplantation; 2007 Dec; 84(11):1527-33. PubMed ID: 18091530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Killer immunoglobulin-like receptors.
    Moretta L; Moretta A
    Curr Opin Immunol; 2004 Oct; 16(5):626-33. PubMed ID: 15342010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relevance of natural killer cell human leucocyte antigen epitopes and killer cell immunoglobulin-like receptors in bone marrow transplantation.
    Witt CS; Christiansen FT
    Vox Sang; 2006 Jan; 90(1):10-20. PubMed ID: 16359351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural killer cell recognition of missing self and haploidentical hematopoietic transplantation.
    Ruggeri L; Mancusi A; Burchielli E; Perruccio K; Aversa F; Martelli MF; Velardi A
    Semin Cancer Biol; 2006 Oct; 16(5):404-11. PubMed ID: 16916611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KIR ligands and prediction of relapse after unrelated donor hematopoietic cell transplantation for hematologic malignancy.
    Hsu KC; Gooley T; Malkki M; Pinto-Agnello C; Dupont B; Bignon JD; Bornhäuser M; Christiansen F; Gratwohl A; Morishima Y; Oudshoorn M; Ringden O; van Rood JJ; Petersdorf E;
    Biol Blood Marrow Transplant; 2006 Aug; 12(8):828-36. PubMed ID: 16864053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Distribution of immunoglobulin like receptor gene in Han population in China and the impact thereof on the HLA-identical sibling hematopoietic stem cell transplantation].
    Dou LP; DA WM; Zhao DD; Wang C; Lu XC; Kang HY; Yan P; Wang FF; Zhu HY; Li HH; Gao CJ; Yu L
    Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(44):3111-4. PubMed ID: 18269867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A defined donor activating natural killer cell receptor genotype protects against leukemic relapse after related HLA-identical hematopoietic stem cell transplantation.
    Verheyden S; Schots R; Duquet W; Demanet C
    Leukemia; 2005 Aug; 19(8):1446-51. PubMed ID: 15973456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.